{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:54:50Z","timestamp":1762955690475},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.cld.2016.12.011","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T07:00:27Z","timestamp":1490857227000},"page":"403-420","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cholestatic Liver Diseases After Liver Transplant"],"prefix":"10.1016","volume":"21","author":[{"given":"Nathalie A.","family":"Pena Polanco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric F.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cld.2016.12.011_bib1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2016.12.011_bib2","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2016.12.011_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.011_bib5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2741\/3966","article-title":"Liver transplantation in chronic cholestatic conditions","volume":"17","author":"Milkiewicz","year":"2012","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/13651820801992542","article-title":"Surgery for cholangiocarcinoma: the role of liver transplantation","volume":"10","author":"Rosen","year":"2008","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.cld.2016.12.011_bib7","unstructured":"United Network for Organ Sharing (UNOS). Available at: https:\/\/www.unos.org\/. Accessed August 31, 2016."},{"issue":"6","key":"10.1016\/j.cld.2016.12.011_bib8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/00365521.2015.1036359","article-title":"Liver transplantation in the Nordic countries - an intention to treat and post-transplant analysis from the Nordic Liver Transplant Registry 1982-2013","volume":"50","author":"Fosby","year":"2015","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2016.12.011_bib9","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/TP.0b013e31821694b3","article-title":"Current trends in living donor liver transplantation for primary sclerosing cholangitis","volume":"91","author":"Goldberg","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.011_bib10","first-page":"315","article-title":"An analysis of the OPTN\/UNOS liver transplant registry","author":"Futagawa","year":"2004","journal-title":"Clin Transpl"},{"issue":"5","key":"10.1016\/j.cld.2016.12.011_bib11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/TP.0b013e31827afb3a","article-title":"Evolving frequency and outcomes of liver transplantation based on etiology of liver disease","volume":"95","author":"Singal","year":"2013","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2016.12.011_bib13","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s11605-010-1256-1","article-title":"Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases\u2013an analysis of the UNOS database","volume":"14","author":"Kashyap","year":"2010","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.cld.2016.12.011_bib14","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/hep.27307","article-title":"Superior survival using living donors and donor-recipient matching using a novel living donor risk index","volume":"60","author":"Goldberg","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2016.12.011_bib15","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2016.12.011_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography","volume":"256","author":"Dave","year":"2010","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.cld.2016.12.011_bib17","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2214\/ajr.166.5.8615253","article-title":"Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease","volume":"166","author":"Sheng","year":"1996","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.cld.2016.12.011_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","article-title":"Recurrence and rejection in liver transplantation for primary sclerosing cholangitis","volume":"18","author":"Fosby","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A\u00a0re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2016.12.011_bib20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00000658-199705000-00004","article-title":"Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience","volume":"225","author":"Goss","year":"1997","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.cld.2016.12.011_bib21","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00007890-199811270-00006","article-title":"Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?","volume":"66","author":"Jeyarajah","year":"1998","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.cld.2016.12.011_bib22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/jlts.2003.50143","article-title":"Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation","volume":"9","author":"Kugelmas","year":"2003","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2016.12.011_bib23","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","author":"Ravikumar","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"9349","key":"10.1016\/j.cld.2016.12.011_bib24","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft","volume":"360","author":"Vera","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cld.2016.12.011_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.cld.2016.12.011_bib26","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.20444","article-title":"Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors","volume":"11","author":"Brandsaeter","year":"2005","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2016.12.011_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2016.12.011_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2010.03402.x","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry","volume":"11","author":"Egawa","year":"2011","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.cld.2016.12.011_bib30","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/j.humpath.2003.07.015","article-title":"Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study","volume":"34","author":"Khettry","year":"2003","journal-title":"Hum Pathol"},{"issue":"6\u20137","key":"10.1016\/j.cld.2016.12.011_bib31","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.clinre.2011.02.007","article-title":"Liver transplantation in PBC and PSC: indications and disease recurrence","volume":"35","author":"Carbone","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cld.2014.05.009","article-title":"Recurrence of nonviral liver diseases after liver transplantation","volume":"18","author":"Graziadei","year":"2014","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.cld.2016.12.011_bib33","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2016.12.011_bib34","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/01.TP.0000113807.74942.D2","article-title":"Roux-en-Y choledochojejunostomy is the method of choice for biliary reconstruction in liver transplantation for primary sclerosing cholangitis","volume":"77","author":"Welsh","year":"2004","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.cld.2016.12.011_bib35","first-page":"275","article-title":"Double balloon enteroscopy for endoscopic retrograde cholangiopancreaticography after Roux-en-Y reconstruction: case series and review of the literature","volume":"66","author":"Koornstra","year":"2008","journal-title":"Neth J Med"},{"issue":"8","key":"10.1016\/j.cld.2016.12.011_bib36","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-0030-1255557","article-title":"Endoscopic retrograde cholangiopancreatography using a single-balloon enteroscope in patients with altered Roux-en-Y anatomy","volume":"42","author":"Saleem","year":"2010","journal-title":"Endoscopy"},{"issue":"1","key":"10.1016\/j.cld.2016.12.011_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1432-2277.2011.01371.x","article-title":"Duct-to-duct biliary reconstruction in orthotopic liver transplantation for primary sclerosing cholangitis: a viable and safe alternative","volume":"25","author":"Damrah","year":"2012","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.cld.2016.12.011_bib38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/tri.12513","article-title":"Meta-analysis of duct-to-duct versus Roux-en-Y biliary reconstruction following liver transplantation for primary sclerosing cholangitis","volume":"28","author":"Pandanaboyana","year":"2015","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.cld.2016.12.011_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/lt.23827","article-title":"Duct-to-duct reconstruction in liver transplantation for primary sclerosing cholangitis is associated with fewer biliary complications in comparison with hepaticojejunostomy","volume":"20","author":"Sutton","year":"2014","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1016\/j.cld.2016.12.011_bib40","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s00268-001-0162-9","article-title":"Changes in bacterial concentration in the liver correlate with that in the hepaticojejunostomy after bile duct reconstruction: implication in the pathogenesis of postoperative cholangitis","volume":"25","author":"Chuang","year":"2001","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.cld.2016.12.011_bib41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-6143.2008.02487.x","article-title":"Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation","volume":"9","author":"Shaked","year":"2009","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.cld.2016.12.011_bib42","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00007890-200008150-00014","article-title":"Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors","volume":"70","author":"Milkiewicz","year":"2000","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.cld.2016.12.011_bib44","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/bjs.1800820836","article-title":"Inflammatory bowel disease in primary sclerosing cholangitis: an analysis of patients undergoing liver transplantation","volume":"82","author":"Miki","year":"1995","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.cld.2016.12.011_bib45","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.1840220213","article-title":"Liver transplantation for sclerosing cholangitis","volume":"22","author":"Narumi","year":"1995","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-0012.2007.00788.x","article-title":"Late acute rejection after liver transplantation impacts patient survival","volume":"22","author":"Uemura","year":"2008","journal-title":"Clin Transpl"},{"issue":"5","key":"10.1016\/j.cld.2016.12.011_bib47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib48","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1572-0241.2004.04050.x","article-title":"Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC","volume":"99","author":"Maheshwari","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib49","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ibd.21699","article-title":"Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients","volume":"18","author":"Jorgensen","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.cld.2016.12.011_bib50","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1365-2036.2012.05067.x","article-title":"The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis","volume":"35","author":"Navaneethan","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cld.2016.12.011_bib51","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","article-title":"Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease","volume":"6","author":"Verdonk","year":"2006","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.cld.2016.12.011_bib52","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1432-2277.2008.00729.x","article-title":"Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far?","volume":"22","author":"Schreuder","year":"2009","journal-title":"Transpl Int"},{"issue":"5","key":"10.1016\/j.cld.2016.12.011_bib53","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2012.12.027","article-title":"Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease","volume":"11","author":"Jorgensen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2016.12.011_bib54","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/ajg.2010.33","article-title":"Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation","volume":"105","author":"El-Nachef","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MEG.0b013e3280116ccc","article-title":"Infliximab for ulcerative colitis following liver transplantation","volume":"19","author":"Lal","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2016.12.011_bib56","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2036.2012.05217.x","article-title":"Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients","volume":"36","author":"Mohabbat","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib57","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.510270308","article-title":"Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation","volume":"27","author":"Loftus","year":"1998","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2016.12.011_bib58","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.TP.0000058744.34965.38","article-title":"Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"75","author":"Vera","year":"2003","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.cld.2016.12.011_bib59","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/j.1572-0241.2000.02269.x","article-title":"Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation","volume":"95","author":"Trautwein","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2016.12.011_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2016.12.011_bib61","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hep.510290229","article-title":"Quality of life before and after liver transplantation for cholestatic liver disease","volume":"29","author":"Gross","year":"1999","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2016.12.011_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2016.12.011_bib63","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2016.12.011_bib64","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/hep.22178","article-title":"Mortality attributable to cholestatic liver disease in the United States","volume":"47","author":"Mendes","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2016.12.011_bib65","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0168-8278(99)80136-6","article-title":"Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial","volume":"30","author":"Angulo","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2016.12.011_bib66","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2016.12.011_bib67","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-6143.2010.03038.x","article-title":"Recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Silveira","year":"2010","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib68","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2013.04.017","article-title":"The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study","volume":"59","author":"Carbone","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 2","key":"10.1016\/j.cld.2016.12.011_bib69","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/lt.21916","article-title":"Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation","volume":"15","author":"Duclos-Vallee","year":"2009","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2016.12.011_bib70","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ajt.13583","article-title":"Long-term outcomes of living-donor liver transplantation for primary biliary cirrhosis: a Japanese multicenter study","volume":"16","author":"Egawa","year":"2016","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.cld.2016.12.011_bib71","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/lt.20511","article-title":"Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant","volume":"11","author":"Guy","year":"2005","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2016.12.011_bib72","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/lt.20856","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis","volume":"13","author":"Morioka","year":"2007","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2016.12.011_bib73","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib74","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0168-8278(96)80001-8","article-title":"Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression","volume":"24","author":"Dmitrewski","year":"1996","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2016.12.011_bib75","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2016.12.011_bib76","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/lt.21960","article-title":"Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity","volume":"16","author":"Manousou","year":"2010","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2016.12.011_bib77","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/lt.21118","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis","volume":"13","author":"Hashimoto","year":"2007","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.cld.2016.12.011_bib78","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2016.12.011_bib79","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/lt.500050419","article-title":"Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis","volume":"5","author":"Heathcote","year":"1999","journal-title":"Liver Transpl Surg"},{"issue":"6","key":"10.1016\/j.cld.2016.12.011_bib80","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jhep.2015.07.038","article-title":"Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence","volume":"63","author":"Bosch","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2016.12.011_bib81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin Transpl"},{"issue":"4","key":"10.1016\/j.cld.2016.12.011_bib82","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.transproceed.2005.03.130","article-title":"Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival","volume":"37","author":"Jacob","year":"2005","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib83","first-page":"35","article-title":"Mayo risk score for primary biliary cirrhosis: a useful tool for the prediction of course after liver transplantation?","volume":"13","author":"Jacob","year":"2008","journal-title":"Ann Transplant"},{"issue":"5","key":"10.1016\/j.cld.2016.12.011_bib84","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.transproceed.2014.02.021","article-title":"Chronic immune-mediated reaction syndrome as the cause of late graft mortality in living-donor liver transplantation for primary biliary cirrhosis","volume":"46","author":"Harimoto","year":"2014","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.cld.2016.12.011_bib85","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00007890-199602270-00007","article-title":"The importance of the effect of underlying disease on rejection outcomes following orthotopic liver transplantation","volume":"61","author":"Berlakovich","year":"1996","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.cld.2016.12.011_bib86","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/lt.500040313","article-title":"Allograft rejection after liver transplantation for autoimmune liver diseases","volume":"4","author":"Hayashi","year":"1998","journal-title":"Liver Transpl Surg"},{"issue":"7","key":"10.1016\/j.cld.2016.12.011_bib87","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/TP.0b013e3182845f6c","article-title":"Late acute liver allograft rejection; a study of its natural history and graft survival in the current era","volume":"95","author":"Thurairajah","year":"2013","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cld.2016.12.011_bib88","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation","volume":"60","author":"Carbone","year":"2014","journal-title":"J\u00a0Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326116301192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326116301192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T10:00:25Z","timestamp":1719136825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326116301192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1089326116301192"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2016.12.011","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholestatic Liver Diseases After Liver Transplant","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2016.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}